The prospect of gene therapy for prostate cancer: update on theory and status
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference40 articles.
1. GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?
2. Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo
3. Transcriptionally regulated adenoviruses for prostate-specific gene therapy
4. Gene therapy: designer promoters for tumour targeting
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 19 F‐NMR detection of lacZ gene expression via the enzymic hydrolysis of 2‐fluoro‐4‐nitrophenyl β‐D‐galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse 1;The FASEB Journal;2007-03-09
2. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer;The Journal of Gene Medicine;2007
3. Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC);Current Medicinal Chemistry;2005-02-01
4. Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate;Prostate Cancer and Prostatic Diseases;2004-10-12
5. Dosimetric and technical considerations for interstitial adenoviral gene therapy as applied to prostate cancer;International Journal of Radiation Oncology*Biology*Physics;2003-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3